Moreover, ANG-2 has been shown to enhance tumour metastasis and immunosuppression by regulating cytokine levels in the tumour microenvironment, suggesting that ANG-2 is a potential target for cancer treatment therapy (64, 65). The gene discussed is ANGPT2; the disease is neoplasm.